---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-007714"
form_type: "8-K"
ticker: "CMPX"
cik: "0001738021"
company_name: "Compass Therapeutics, Inc."
filed_at: "2022-11-29T23:59:59+00:00"
generated_at: "2026-06-21T12:21:59.458924+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Compass Therapeutics CSO Susan Kalled departs effective Nov 29, 2022

## Summary
- Susan Kalled, PhD, resigned as Chief Scientific Officer on November 29, 2022.
- Entitled to 12 months base salary severance paid in installments over 12 months.
- Eligible for up to 12 months COBRA premium reimbursement, contingent on separation agreement.

## SEC filing metadata
- accession: 0001171843-22-007714
- form_type: 8-K
- ticker: CMPX
- cik: 0001738021
- company_name: Compass Therapeutics, Inc.
- filed_at: 2022-11-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1738021/000117184322007714/0001171843-22-007714-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1738021/000117184322007714/f8k_112922.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-007714
- JSON: https://secwatch.observer/filing/0001171843-22-007714.json
- Plain text: https://secwatch.observer/filing/0001171843-22-007714.txt

## Key facts
- Executive change
  Susan Kalled, PhD departed as Chief Scientific Officer at Compass Therapeutics, Inc..
  - Action: departed
  - Role: Chief Scientific Officer
  source text: On November 29, 2022, Susan Kalled, PhD departed her position as Chief Scientific Officer of Compass Therapeutics, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1738021/000117184322007714/0001171843-22-007714-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
